Morus Alba leaf extract affects metabolic profiles, biomarkers inflammation and oxidative stress in patients with type 2 diabetes mellitus: A double-blind clinical trial.
- 2022-06
- RCT · n = 60
- Clinical nutrition ESPEN 49
- Mohsen Taghizadeh
- Azam Mohammad Zadeh
- Zatollah Asemi
- Amir Hosein Farrokhnezhad
- Mohammad Reza Memarzadeh
- Zarin Banikazemi
- Mohammad Shariat
- Rana Shafabakhsh
- PubMed: 35623877
- DOI: 10.1016/j.clnesp.2022.03.027
- High evidence
- Clinical
Morus Alba extract intake significantly decreased insulin (P = 0.026) and malondialdehyde (MDA) (P < 0.001), and significantly increased HDL-cholesterol concentrations (P = 0.001) compared with the placebo.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 300 mg twice a day